ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,216.82
0.32%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. PainReform Ltd (PRFX)

  7. PainReform Ltd (PRFX) Noticias

PRFX PainReform Ltd

0.5225
-0.0277 (-5.03%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
PainReform Ltd PRFX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0277 -5.03% 0.5225 23:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.5617 0.48 0.5743 0.52 0.5502
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
31/5/202415:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202415:15GLOBEPainReform Announces Receipt of Nasdaq Minimum Bid Price..
15/5/202415:05GLOBEPainReform Provides Business Update for the First Quarter of..
08/5/202407:30GLOBEPainReform CEO Ilan Hadar Discusses Latest Developments..
18/4/202413:19GLOBEPainReform Announces Closing of $4 Million Public Offering
16/4/202407:00GLOBEPainReform Announces Pricing of $4 Million Public Offering
09/4/202408:00GLOBEPainReform’s Non-Opiate Topical Treatment for Post-Surgical..
02/4/202407:30GLOBEPainReform Reaches 50% Enrollment in the Second Part of its..
07/3/202416:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202415:34EDGAR2Form F-1 - Registration statement for certain foreign..
01/3/202407:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202407:00GLOBEPainReform Provides Year-End Business Update
29/2/202415:37EDGAR2Form 20-F - Annual and transition report of foreign private..
22/1/202407:30GLOBEPainReform to Present at the Microcap Conference in Atlantic..
21/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
19/1/202415:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/1/202415:15EDGAR2Form F-3 - Registration statement by foreign private issuers
03/1/202407:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202407:30GLOBEPainReform Reports Successful Head-to-Head Comparison of..
27/12/202315:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/12/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/12/202317:00GLOBEPainReform Announces Exercise of Warrants for Approximately..
15/11/202315:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202315:05GLOBEPainReform Provides Business Update for the Third Quarter of..
11/9/202307:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202307:30GLOBEPainReform Announces Plans to Commence Second Part of Phase..
07/9/202309:00GLOBEPainReform Selected for Poster Presentation at the 13th..
05/9/202315:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/9/202307:30GLOBEPainReform to Participate in the H.C. Wainwright 25th Annual..
25/8/202315:15EDGAR2Form F-1 - Registration statement for certain foreign..
10/8/202315:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202315:05GLOBEPainReform Provides Business Update for the Second Quarter..
19/7/202308:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/7/202308:00GLOBEPainReform Regains Compliance with Nasdaq Continued Listing..
18/7/202310:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/7/202310:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/7/202314:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/7/202313:35GLOBEPainReform Announces Pricing of $1.5 Million Concurrent..
14/7/202311:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/7/202311:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202308:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202308:05GLOBEPainReform Announces Pricing of $2.7 Million Concurrent..
29/6/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

NASDAQ
PRFX
PainReform
LSE
44PD
Municplty 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados